|
2025
|
Invention
|
Heterocyclic compound and use thereof as ret inhibitor. The present disclosure relates to a novel... |
|
2024
|
Invention
|
Pyridine-2(1h)-one prmt5-mta inhibitor, and pharmaceutical composition and use thereof. Provided ... |
|
|
Invention
|
Compound for regulating tead activity, preparation method therefor, and use thereof. The present ... |
|
|
Invention
|
Use of pharmaceutical composition comprising compound having bis(azanylylidene) sulfonyl structur... |
|
|
Invention
|
Compound for regulating and controlling 15-pgdh activity and preparation method therefor. The pre... |
|
|
Invention
|
New use of compound containing bi(azetidinylidene) sulfonyl structure as pkm2 agonist. The presen... |
|
|
Invention
|
Compound having clk and dyrk inhibitory activity, preparation method therefor and use thereof. Th... |
|
2023
|
Invention
|
Quinazoline compound and use thereof. Provided in the present application are a quinazoline compo... |
|
|
Invention
|
Compound for regulating and controlling activity of 15-pgdh and preparation method therefor. A co... |
|
|
Invention
|
Compound for regulating and controlling activity of 15-pgdh and preparation method therefor. Prov... |
|
|
Invention
|
Use of tetrahydronaphthyridine derivative for preparing product for improving hyperpigmentation. ... |
|
|
Invention
|
Use of tetrahydronaphthyridine derivative for preparation of medicine for preventing and treating... |
|
|
Invention
|
Compound capable of regulating and controlling activity of 15-pgdh, and preparation method theref... |
|
|
Invention
|
Methionine adenosyltransferase inhibitor, preparation method therefor and use thereof. Provided i... |
|
|
Invention
|
Compound for regulating and controlling 15-pgdh activity and preparation method therefor.
The pr... |
|
|
Invention
|
Quinazoline derivative and use thereof. Provided are a quinazoline derivative represented by gene... |
|
2022
|
Invention
|
Compound containing bis(azanylylidene) sulfonyl structure and use thereof in medicine.
A compoun... |
|
|
Invention
|
Compound containing bis(azanylylidene) sulfonyl structure and use thereof in medicine. A compound... |
|
|
Invention
|
Compound having clk and dyrk inhibitory activities, preparation method therefor and use thereof. ... |
|
|
Invention
|
Amino-containing macrocyclic compound as protein kinase modulator. Provided are a compound which ... |
|
|
P/S
|
Technological research in the field of computer hardware systems, renewable energy resources; qua... |
|
|
Invention
|
Methionine adenosyltransferase inhibitor, preparation method therefor and application thereof.
D... |
|
|
Invention
|
Methionine adenosyltransferase inhibitor, preparation method therefor and application thereof. 12... |
|
|
Invention
|
Solid form of fluorine-containing macrocyclic structure compound, preparation method, and applica... |
|
|
Invention
|
Plasmin inhibitor, preparation method therefor, and application thereof.
The present invention r... |
|
|
Invention
|
Plasmin inhibitor, preparation method therefor, and application thereof. 133 are as defined in th... |
|
2021
|
Invention
|
Plasmin inhibitor, preparation method therefor and application thereof.
A compound of formula (I... |
|
|
Invention
|
Plasmin inhibitor, and preparation method therefor and application thereof. 155 are as defined in... |
|
|
Invention
|
Methionine adenosyltransferase inhibitor, preparation method therefor, and application thereof. C... |
|
|
Invention
|
Application of fluorine-containing heterocyclic derivative having macrocyclic structure. The pres... |
|
|
Invention
|
Heterocyclic compound and derivative thereof. The present application relates to a heterocyclic c... |
|
|
Invention
|
Compound having macrocyclic structure and use thereof.
The present invention relates to a compou... |
|
2020
|
Invention
|
Fluorine-containing heterocyclic derivatives with macrocyclic structure and use thereof. Disclose... |
